Literature DB >> 27297362

IL-6/STAT3 axis initiated CAFs via up-regulating TIMP-1 which was attenuated by acetylation of STAT3 induced by PCAF in HCC microenvironment.

Xin Zheng1, Meng Xu2, Bowen Yao3, Cong Wang4, Yuli Jia5, Qingguang Liu6.   

Abstract

Aberrant tumor microenvironment is involved closely in tumor initiation and progression, in which cancer associated fibroblasts (CAFs) play a pivotal role. Both IL-6/STAT3 signaling and TIMP-1 have been found to modulate the crosstalk between tumor cells and CAFs in tumor microenvironment, however, the underlying mechanism remains unclear. Here, we showed that IL-6/STAT3 signaling was activated aberrantly in HCC tissues and correlated with poor post-surgical outcome. The in vitro experiments confirmed that activation of IL-6/STAT3 pathway enhanced TIMP-1 expression directly via phosphorylated STATs (p-STAT3)-binding with TIMP-1 promoter in Huh7 cells. Furthermore, activation of IL-6/STAT3 pathway in HCC cells was shown to induce the transformation from normal liver fibroblasts (LFs) to CAFs via up-regulating TIMP-1 expression. Co-culture with CAFs promoted the growth of Huh7 cells both in vitro and in vivo. Finally, by co-Immunoprecipitation and immunoblotting assessments, PCAF, a well-known acetyltransferase, was revealed to acetylate cytoplasmic STAT3 protein directly and regulate TIMP-1 expression negatively in Huh7 cells. In summary, this investigation indicated that there was a positive IL-6/TIMP-1 feedback loop controlling the crosstalk between HCC cells and its neighbouring fibroblasts. The data here also identified that PCAF repressed TIMP-1 expression via acetylation of STAT3. In conclusion, this investigation demonstrated that CAFs promoted HCC growth via IL-6/STAT3/AKT pathway and TIMP-1 over-expression driven by IL-6/STAT3 pathway in HCC cells brought in more CAFs through activating LFs. Finally, PCAF could block this positive feedback by acetylating STAT3 in HCC cells.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CAFs; HCC; IL-6/STAT3/AKT; TIMP-1

Mesh:

Substances:

Year:  2016        PMID: 27297362     DOI: 10.1016/j.cellsig.2016.06.009

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  26 in total

1.  Cancer-associated fibroblasts promote the stemness of CD24+ liver cells via paracrine signaling.

Authors:  Yawen Li; Ronghua Wang; Si Xiong; Xiju Wang; Zhenxiong Zhao; Shuya Bai; Yun Wang; Yuchong Zhao; Bin Cheng
Journal:  J Mol Med (Berl)       Date:  2018-12-18       Impact factor: 4.599

2.  Cancer-associated fibroblasts promote colorectal cancer progression by secreting CLEC3B.

Authors:  Hui-Fang Zhu; Xu-Hui Zhang; Chuan-Sha Gu; Yan Zhong; Ting Long; Yi-Dan Ma; Zhi-Yan Hu; Zu-Guo Li; Xiao-Yan Wang
Journal:  Cancer Biol Ther       Date:  2019-03-20       Impact factor: 4.742

3.  Cancer-associated fibroblasts promote stem cell-like properties of hepatocellular carcinoma cells through IL-6/STAT3/Notch signaling.

Authors:  Si Xiong; Ronghua Wang; Qian Chen; Jing Luo; Jinlin Wang; Zhenxiong Zhao; Yawen Li; Yun Wang; Xiju Wang; Bin Cheng
Journal:  Am J Cancer Res       Date:  2018-02-01       Impact factor: 6.166

4.  Identification of novel proteins in chemoresistant lung cancer cells by quantitative proteomics.

Authors:  Li Su; Jiao Liu; Hongying Zhen
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

5.  Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer.

Authors:  Shulin Xiang; Robert T Dauchy; Aaron E Hoffman; David Pointer; Tripp Frasch; David E Blask; Steven M Hill
Journal:  J Pineal Res       Date:  2019-06-09       Impact factor: 13.007

Review 6.  Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma.

Authors:  Yue Chen; Haoyue Hu; Xianglei Yuan; Xue Fan; Chengda Zhang
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

7.  Myeloid-Derived TSP1 (Thrombospondin-1) Contributes to Abdominal Aortic Aneurysm Through Suppressing Tissue Inhibitor of Metalloproteinases-1.

Authors:  Huan Yang; Ting Zhou; Christine M Sorenson; Nader Sheibani; Bo Liu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-08       Impact factor: 8.311

8.  Early Plasma Matrix Metalloproteinase Profiles. A Novel Pathway in Pediatric Acute Respiratory Distress Syndrome.

Authors:  Matt S Zinter; Kevin L Delucchi; Michele Y Kong; Benjamin E Orwoll; Aaron S Spicer; Michelle J Lim; Mustafa F Alkhouli; Anna E Ratiu; Anne V McKenzie; Patrick S McQuillen; Christopher C Dvorak; Carolyn S Calfee; Michael A Matthay; Anil Sapru
Journal:  Am J Respir Crit Care Med       Date:  2019-01-15       Impact factor: 30.528

9.  STAT3 induces breast cancer growth via ANGPTL4, MMP13 and STC1 secretion by cancer associated fibroblasts.

Authors:  Lidia Avalle; Laura Raggi; Emanuele Monteleone; Aurora Savino; Daniele Viavattene; Luisa Statello; Andrea Camperi; Simona Aversano Stabile; Vincenzo Salemme; Niccolò De Marzo; Francesca Marino; Chiara Guglielmi; Andrea Lobascio; Cristina Zanini; Marco Forni; Danny Incarnato; Paola Defilippi; Salvatore Oliviero; Valeria Poli
Journal:  Oncogene       Date:  2022-01-18       Impact factor: 8.756

10.  Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers.

Authors:  Julia S Johansen; Jesper B Andersen; Dan Høgdall; Colm J O'Rourke; Christian Dehlendorff; Ole F Larsen; Lars H Jensen; Astrid Z Johansen; Hien Dang; Valentina M Factor; Mie Grunnet; Morten Mau-Sørensen; Douglas V N P Oliveira; Dorte Linnemann; Mogens K Boisen; Xin W Wang
Journal:  Clin Cancer Res       Date:  2020-09-15       Impact factor: 13.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.